The Latest in Multiple Sclerosis

Clinical Neurology News

Is MS caused by one-two punch of pinworm and Epstein-Barr virus?

February 22, 2018

Multiple Sclerosis

Neurology Reviews

Do Neurologists Adequately Screen Patients With MS for Cognitive Impairment and Depression?

February 14, 2018

Multiple Sclerosis

Clinical Neurology News

Study identifies characteristics that may constitute the MS prodrome

February 11, 2018

Multiple Sclerosis

Clinical Neurology News

Physicians often bypass cognition, depression screening in MS

February 11, 2018

Multiple Sclerosis

Clinical Neurology News

Nearly half of MS patients treated by primary docs miss out on meds

February 9, 2018

Multiple Sclerosis

Clinical Neurology News

VIDEO: Teriflunomide and dimethyl fumarate are comparable in relapsing-remitting MS

February 9, 2018

Multiple Sclerosis

Neurology Reviews

Adil Harroud, MD

February 9, 2018

Multiple Sclerosis

Clinical Neurology News

VIDEO: Advanced practice providers take on many roles in MS care

February 7, 2018

Multiple Sclerosis

Clinical Neurology News

‘Real-world evidence’ used to compare agents for relapsing-remitting MS

February 7, 2018

Multiple Sclerosis

Clinical Neurology News

Trial of clozapine, risperidone halted in MS

February 6, 2018

Multiple Sclerosis

Neurology Reviews

MAGNIMS and McDonald Criteria Have Similar Accuracy

February 5, 2018

Multiple Sclerosis

Neurology Reviews

Rituximab May Provide Greater Benefits Than Other First-Line MS Therapies

February 5, 2018

Multiple Sclerosis

Neurology Reviews

MS: Past, Present, and Future

February 5, 2018

Multiple Sclerosis

Clinical Neurology News

VIDEO: Managing the alemtuzumab paradox

February 3, 2018

Multiple Sclerosis

Clinical Neurology News

Third course of alemtuzumab can improve MS outcomes

February 3, 2018

Multiple Sclerosis